Cutaneous Metastasis as a Presenting Feature of Renal Adenocarcinoma in a Renal Transplant Recipient: A Case Report

Nikolina Basic-Jukic; Ines Mesar; Jason Kirincich

doi:10.1016/j.transproceed.2019.04.021

Cutaneous Metastasis as a Presenting Feature of Renal Adenocarcinoma in a Renal Transplant Recipient: A Case Report

Transplant Proc. 2019 Nov;51(9):3072-3073. doi: 10.1016/j.transproceed.2019.04.021. Epub 2019 Oct 11.

Authors

Nikolina Basic-Jukic¹, Ines Mesar², Jason Kirincich³

Affiliations

¹ Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia. Electronic address: nina_basic@net.hr.
² Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb, Croatia.
³ School of Medicine, University of Zagreb, Zagreb, Croatia.

PMID: 31611123
DOI: 10.1016/j.transproceed.2019.04.021

Abstract

Cutaneous metastases of urological malignancies are a rare phenomenon. We present a case of a renal transplant recipient who presented with skin nodule 12 years posttransplant. Pathohistologic evaluation revealed metastasis from the renal adenocarcinoma. The patient was treated with temsirolimus and later with sorafenib; however, he died 13 months after the initial presentation with a functional renal allograft.

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / therapeutic use
Carcinoma, Renal Cell / drug therapy
Carcinoma, Renal Cell / secondary*
Humans
Kidney Neoplasms / drug therapy
Kidney Neoplasms / pathology*
Kidney Transplantation*
Male
Middle Aged
Sirolimus / analogs & derivatives
Sirolimus / therapeutic use
Skin Neoplasms / drug therapy
Skin Neoplasms / secondary*
Transplant Recipients
Transplantation, Homologous

Substances

Antineoplastic Agents
temsirolimus
Sirolimus